Latest PEG ratio for Forward Pharma A/S: -560.08 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-560.08
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for FWP is -560.08. That is below the Healthcare sector average of 2.56. Investors often review this figure alongside Forward Pharma A/S's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, FWP currently prints -560.08 for PEG ratio, while the sector average sits near 2.56. That is roughly 21980.4% below the sector mean. Large gaps often invite a closer look at Forward Pharma A/S's growth, margins, and balance sheet.
A PEG ratio of -560.08 for Forward Pharma A/S is not 'good' or 'bad' on its own. Compare it with the peer average (2.56) and with FWP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting FWP's PEG ratio (-560.08), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Forward Pharma A/S's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.